BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tin Tin Htar M, van Den Biggelaar AHJ, Sings H, Ferreira G, Moffatt M, Hall-Murray C, Verstraeten T, Gessner BD, Schmitt HJ, Jodar L. The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review. Expert Rev Vaccines 2019;18:1069-89. [PMID: 31585049 DOI: 10.1080/14760584.2019.1676155] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Gutiérrez-Tobar IF, Londoño-Ruiz JP, Mariño-Drews C, Beltrán-Higuera S, Camacho-Moreno G, Leal-Castro AL, Patiño-Niño JA, Álvarez-Olmos MI, Barrero-Barreto R, Espinosa F, Suarez MA, Ramos N, Moreno-Mejia VM, Marín A, Sierra Parada CR, Pescador A, Montañez A. Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008-2019. Vaccine 2022:S0264-410X(22)00299-7. [PMID: 35396166 DOI: 10.1016/j.vaccine.2022.03.022] [Reference Citation Analysis]
2 Chevalier-Cottin EP, Ashbaugh H, Brooke N, Gavazzi G, Santillana M, Burlet N, Tin Tin Htar M. Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases. Infect Dis Ther 2020;9:467-80. [PMID: 32583334 DOI: 10.1007/s40121-020-00312-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wasserman M, Chapman R, Lapidot R, Sutton K, Dillon-Murphy D, Patel S, Chilson E, Snow V, Farkouh R, Pelton S. Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children. Emerg Infect Dis 2021;27:1627-36. [PMID: 34013855 DOI: 10.3201/eid2706.204238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ackley ER, Tchou MJ, Press CA, Parker SK, Dominguez SR, Gaensbauer J, Messacar K. AKI In Suspected Meningitis/Encephalitis May Be "Avoidable Kidney Injury". Hosp Pediatr 2021;11:e167-9. [PMID: 34244336 DOI: 10.1542/hpeds.2020-005770] [Reference Citation Analysis]
5 Abotsi RE, Nicol MP, McHugh G, Simms V, Rehman AM, Barthus C, Mbhele S, Moyo BW, Ngwira LG, Mujuru H, Makamure B, Mayini J, Odland JØ, Ferrand RA, Dube FS. Prevalence and antimicrobial resistance profiles of respiratory microbial flora in African children with HIV-associated chronic lung disease. BMC Infect Dis 2021;21:216. [PMID: 33632144 DOI: 10.1186/s12879-021-05904-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chapman R, Sutton K, Dillon-Murphy D, Patel S, Hilton B, Farkouh R, Wasserman M. Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis. Vaccine 2020;38:7138-45. [PMID: 32912642 DOI: 10.1016/j.vaccine.2020.08.068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Negash AA, Asrat D, Abebe W, Aseffa A, Vaneechoutte M. Phenotypic and Molecular Characterization of Penicillin and Macrolide-Resistant Streptococcus pneumoniae Serotypes Among Pediatric Patients in Addis Ababa, Ethiopia. Infect Drug Resist 2021;14:1765-72. [PMID: 34012275 DOI: 10.2147/IDR.S309876] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Thomas RE. Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and Mortality. Geriatrics (Basel) 2021;6:13. [PMID: 33557406 DOI: 10.3390/geriatrics6010013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Doherty TM, Hausdorff WP, Kristinsson KG. Effect of vaccination on the use of antimicrobial agents: a systematic literature review. Ann Med 2020;52:283-99. [PMID: 32597236 DOI: 10.1080/07853890.2020.1782460] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Varghese R, Daniel JL, Neeravi A, Baskar P, Manoharan A, Sundaram B, Manchanda V, Saigal K, Yesudhasan BL, Veeraraghavan B. Multicentric Analysis of Erythromycin Resistance Determinants in Invasive Streptococcus pneumoniae; Associated Serotypes and Sequence Types in India. Curr Microbiol 2021;78:3239-45. [PMID: 34223923 DOI: 10.1007/s00284-021-02594-7] [Reference Citation Analysis]
11 Horn EK, Wasserman MD, Hall-Murray C, Sings HL, Chapman R, Farkouh RA. Public health impact of pneumococcal conjugate vaccination: a review of measurement challenges. Expert Rev Vaccines 2021;20:1291-309. [PMID: 34424123 DOI: 10.1080/14760584.2021.1971521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Alfayate Miguélez S, Yague Guirao G, Menasalvas Ruíz AI, Sanchez-Solís M, Domenech Lucas M, González Camacho F, Ortíz Romero MM, Espejo García P, Guerrero Gómez C, Iofrío de Arce A, Moreno Parrado L, Sánchez Andrada RM, Cascales Alcolea E, Lorente García S, Paredes Reyes P, Casquet Barceló Á, López Yepes ML, Vigueras Abellán JJ, Sanz Mateo G, Murcian Pneumococcal Study Group. Impact of Pneumococcal Vaccination in the Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children of the Murcia Region in Spain. Vaccines (Basel) 2020;9:14. [PMID: 33379235 DOI: 10.3390/vaccines9010014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Izurieta P, Scherbakov M, Nieto Guevara J, Vetter V, Soumahoro L. Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media. Hum Vaccin Immunother 2022;:1-18. [PMID: 35020530 DOI: 10.1080/21645515.2021.2013693] [Reference Citation Analysis]
14 Suaya JA, Mendes RE, Sings HL, Arguedas A, Reinert R, Jodar L, Isturiz RE, Gessner BD. Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017. Journal of Infection 2020;81:557-66. [DOI: 10.1016/j.jinf.2020.07.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
15 Pauna HF, Knoll RM, Lubner RJ, Brodsky JR, Cushing SL, Hyppolito MA, Nadol JB Jr, Remenschneider AK, Kozin ED. Histopathological changes to the peripheral vestibular system following meningitic labyrinthitis. Laryngoscope Investig Otolaryngol 2020;5:256-66. [PMID: 32337357 DOI: 10.1002/lio2.349] [Reference Citation Analysis]
16 Kim HY, Park SB, Kang ES, Lee SM, Kim HJ, Wasserman M. Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea. Hum Vaccin Immunother 2021;17:909-18. [PMID: 32783576 DOI: 10.1080/21645515.2020.1796426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Perdrizet J, Farkouh RA, Horn EK, Hayford K, Sings HL, Wasserman MD. The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines. Expert Rev Vaccines 2022;:1-13. [PMID: 35191368 DOI: 10.1080/14760584.2022.2040989] [Reference Citation Analysis]